To support this mechanism, a recent study has demonstrated that in mice treated with bleomycin, which induces pulmonary fibrosis, the administration of rapamycin, by inhibiting mTOR, prevents EMT in epithelial alveolar cells (Han et al., 2018). The gene discussed is MTOR; the disease is pulmonary fibrosis.